Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Arthur J. Gallagher & Co
AJG
$67.6B
| $5.47M | 0.09% |
62,437
+58,095
| +1,338% | +$4.85M |
|
302
Bunge Global
BG
$21.7B
| $5.44M | 0.09% |
97,710
-100,738
| -51% | -$5.37M |
|
303
Dentsply Sirona
XRAY
$2.18B
| $5.43M | 0.09% |
93,067
-50
| -0.1% | -$2.69K |
|
304
Reliance Steel & Aluminium
RS
$19.8B
| $5.42M | 0.09% |
57,322
+49,661
| +648% | +$4.45M |
|
305
Schneider National
SNDR
$6.28B
| $5.39M | 0.09% |
295,684
+114,432
| +63% | +$2.22M |
|
|
FLOW
306
DELISTED
SPX FLOW, Inc.
FLOW
| $5.38M | 0.09% |
128,640
+42,466
| +49% | +$1.57M |
|
307
Travelers Companies
TRV
$75.8B
| $5.38M | 0.09% |
35,981
+25,403
| +240% | +$3.66M |
|
308
Bloomin' Brands
BLMN
$996M
| $5.37M | 0.09% |
283,926
+270,083
| +1,951% | +$5.28M |
|
309
Cincinnati Financial
CINF
$25.8B
| $5.34M | 0.09% |
+51,551
| New | +$4.95M |
|
310
Manhattan Associates
MANH
$12.5B
| $5.31M | 0.08% |
76,597
-299
| -0.4% | -$19.3K |
|
311
Arista Networks
ANET
$238B
| $5.3M | 0.08% |
326,624
+302,912
| +1,277% | +$5.24M |
|
312
Paylocity
PCTY
$8.14B
| $5.16M | 0.08% |
55,040
+52,265
| +1,883% | +$4.96M |
|
313
Delta Air Lines
DAL
$54.2B
| $5.12M | 0.08% |
90,153
-153,539
| -63% | -$8.6M |
|
314
W.W. Grainger
GWW
$61.8B
| $5.1M | 0.08% |
19,013
-13,707
| -42% | -$3.85M |
|
|
ANSS
315
DELISTED
Ansys
ANSS
| $5.06M | 0.08% |
24,720
-25,320
| -51% | -$4.82M |
|
316
EQT Corp
EQT
$33.6B
| $5.02M | 0.08% |
317,376
+282,727
| +816% | +$5.42M |
|
317
Analog Devices
ADI
$182B
| $4.99M | 0.08% |
44,208
+22,775
| +106% | +$2.47M |
|
|
HZNP
318
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.98M | 0.08% |
207,158
+139,840
| +208% | +$3.55M |
|
319
MongoDB
MDB
$34.7B
| $4.98M | 0.08% |
32,722
+22,434
| +218% | +$3.26M |
|
320
Deluxe
DLX
$1.08B
| $4.97M | 0.08% |
122,291
-94,063
| -43% | -$3.97M |
|
321
Alcoa
AA
$13.7B
| $4.96M | 0.08% |
211,661
-42,751
| -17% | -$1.07M |
|
322
Thermo Fisher Scientific
TMO
$233B
| $4.89M | 0.08% |
16,661
-23,940
| -59% | -$6.59M |
|
323
Omnicell
OMCL
$1.62B
| $4.89M | 0.08% |
56,835
+18,956
| +50% | +$1.54M |
|
324
Allison Transmission
ALSN
$11B
| $4.81M | 0.08% |
103,765
-135,668
| -57% | -$6.15M |
|
325
A.O. Smith
AOS
$8.57B
| $4.78M | 0.08% |
101,267
-59,291
| -37% | -$2.91M |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.